Datavault AI Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity
CONSOLIDATED STATEMENTS OF CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
(in thousands, except share data)
| | | | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · · · · · · · · · · · · · Total | ||||||||||||||||||||
| · · Convertible Preferred Stock · · · Common Shares · · Additional · · Accumulated · · Stockholders’ | ||||||||||||||||||||
| · Shares · Amount · · Shares · Amount · Paid-in Capital · Deficit · Equity (Deficit) | ||||||||||||||||||||
| Balance as of December 31, 2022 | — | | — | | 4,750 | $1 | | $226,324 | $(228,321) | $(1,996) | ||||||||||
| Stock-based compensation | | — | | | — | | | 6,427 | | | — | | | 2,058 | | | — | | | 2,058 |
| Restricted stock awards cancelled | | — | | | — | | | (88) | | | — | | | — | | | — | | | — |
| Release of vested restricted common stock | | — | | | — | | | 19 | | | — | | | — | | | — | | | — |
| Issuance of common stock in connection with convertible promissory note | | — | | | — | | | 450 | | | — | | | 708 | | | — | | | 708 |
| Issuance of common stock in connection with warrant exercise | | — | | | — | | | 19,030 | | | — | | | 10,713 | | | — | | | 10,713 |
| Issuance of common stock and warrants, net of offering costs | | — | | | — | | | 14,510 | | | — | | | 2,319 | | | — | | | 2,319 |
| Issuance of Series B preferred stock, net of discounts | | 87,000 | | | — | | | — | | | — | | | 1,909 | | | — | | | 1,909 |
| Issuance of Series B preferred stock in connection with warrant exercise, net of discounts | | 61,613 | | | 3,550 | | | — | | | — | | | 195 | | | — | | | 195 |
| Issuance of common stock in connection with conversion of Series B preferred stock | | (110,278) | | | (6,341) | | | 177,282 | | | — | | | 6,341 | | | — | | | 6,341 |
| Deemed dividend in connection with conversion of Series B preferred stock to common stock | | | | | 6,063 | | | — | | | — | | | (6,063) | | | — | | | (6,063) |
| Repurchase of common stock warrants | | — | | | — | | | — | | | — | | | (2,323) | | | — | | | (2,323) |
| Deemed dividend in connection with amortization and accretion of discounts relating to Series B preferred stock | | — | | | 297 | | | — | | | — | | | (297) | | | — | | | (297) |
| Discount from issuance of common stock warrants in connection with Series B preferred stock inducement | | — | | | (3,322) | | | — | | | — | | | — | | | — | | | — |
| Net loss | | — | | | — | | | — | | | — | | | — | | | (18,721) | | | (18,721) |
| Balance as of December 31, 2023 | | 38,335 | | $247 | | | 222,380 | | $1 | | $241,884 | | $(247,042) | | $(5,157) | |||||
| Stock-based compensation | | — | | | — | | | 1,233,683 | | | — | | | 2,536 | | | — | | | 2,536 |
| Restricted stock awards cancelled | | — | | | — | | | (3,941) | | | — | | | — | | | — | | | — |
| Issuance of common stock in connection with warrant amendment | | — | | | — | | | 887,356 | | | — | | | — | | | — | | | — |
| Issuance of common stock in connection with warrant exercise | | — | | | — | | | 5,456,986 | | | — | | | 7,794 | | | — | | | 7,794 |
| Issuance of common stock and warrants, net of offering costs | | — | | | — | | | 2,466,583 | | | — | | | 8,756 | | | — | | | 8,756 |
| Issuance of Series B preferred stock in connection with warrant exercise, net of discounts | | 29,322 | | | 386 | | | — | | | — | | | — | | | — | | | — |
| Issuance of common stock in connection with conversion of Series B preferred stock | | (5,000) | | | (325) | | | 8,038 | | | — | | | 325 | | | — | | | 325 |
| Deemed dividend on conversion of Series B preferred for common stock and repurchase of Series B preferred stock | | — | | | 5,842 | | | — | | | — | | | (5,842) | | | — | | | (5,842) |
| Repurchase of Series B preferred stock and Series B preferred stock warrants | | (62,657) | | | (6,266) | | | — | | | — | | | 824 | | | — | | | 824 |
| Issuance of common stock, pre-funded units and warrants, net of offering costs | | — | | | — | | | 1,442,518 | | | — | | | 4,210 | | | — | | | 4,210 |
| Issuance of common stock in connection with reverse split rounding-up for fractional shares | | — | | | — | | | 84,254 | | | — | | | — | | | — | | | — |
| Issuance of common stock to vendors | | — | | | — | | | 236,203 | | | — | | | 600 | | | — | | | 600 |
| Issuance of common stock in connection with the acquisition of intangible assets | | — | | | — | | | 40,000,000 | | | 4 | | | 81,995 | | | — | | | 81,999 |
| Conversion of liability warrants to equity warrants | | — | | | — | | | — | | | — | | | 41,851 | | | — | | | 41,851 |
| Warrants classified to liability | | — | | | — | | | — | | | — | | | (645) | | | — | | | (645) |
| Cumulative effect of ASU 2020-06 adoption | | — | | | 116 | | | — | | | — | | | (116) | | | — | | | (116) |
| Net loss | | — | | | — | | | — | | | — | | | — | | | (51,409) | | | (51,409) |
| Balance as of December 31, 2024 | | — | | | — | | | 52,034,060 | | $5 | | $384,172 | | $(298,451) | | $85,726 | ||||
Note: Share and per share amounts have been retroactively adjusted to reflect the impact of a 1-for-100 reverse stock split effected in January 2023 as well as a 1-for-150 reverse stock split effected in April 2024, as discussed in Note 1.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.